EUCTR2011-005503-33-PL进行中（未招募）不适用
A Phase 1, Open-label Study to Evaluate the Pharmacokinetics of Tralokinumab in Adolescents with Asthma
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Age 12-17 years (inclusive)
- •Weight > 30kg
- •Asthma for a minimum of 6 months
- •Effective birth control for both male and female participants in line with protocol details.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 20
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Previously taken tralokinumab (the study drug)
- •Employee of the clinical study site or any other individuals directly involved with the conduct of the study, or immediate family members of such individuals.
- •Pregnant or breastfeeding women
- •Current smoker or cessation < 3 months
- •Known immune deficiency
- •History of cancer
- •Hepatitis B, C or HIV
- •Any disease which may cause complications whilst taking the study drug
研究者
相似试验
进行中（未招募）
1 期
A Clinical Study to Investigate the Effects of MEDI9929, a Drug Under Investigation, in Adolescents with Mild to Moderate AsthmaAsthmaMedDRA version: 18.1Level: PTClassification code 10003553Term: AsthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2014-005450-19-PLMedImmune LLC (a wholly owned subsidiary of AstraZeneca PLC)
已完成
1 期
A study about how ASP5354 affects the body in healthy adults and in adults whose kidneys do not work wellJPRN-jRCT2031220304Gabriel P. Haas28
进行中（未招募）
1 期
A study to evaluate how the body processes the drug tezepelumab (pharmacokinetics) in children 5 to 11 Years of age with asthmaEUCTR2020-000554-97-GBAstraZeneca AB14
进行中（未招募）
1 期
A study to evaluate how the body processes the drug tezepelumab (pharmacokinetics) in children 5 to 11 Years of age with asthmaMild, moderate or severe asthmaMedDRA version: 20.0Level: PTClassification code 10003553Term: AsthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2020-000554-97-HUAstraZeneca AB14
尚未招募
不适用
An Open-Label, Phase I Study to Evaluate the Pharmacokinetics and Tolerance of Co-administration of Oral Multiple Dose of Ketoconazole and an IV (bolus) Infusion of Eribulin in Patients with Advanced Solid TumorsCancerNL-OMON33694Eisai12